The Frost & Sullivan Digital Transformation Blog
A collection of expert insights and industry news to help you accelerate growth.
Featured
Sign Up
Sign up to get Frost & Sullivan’s best
and newest content delivered weekly to your inbox.
Identity Security in the Age of AI Agents and Autonomous Digital Ecosystems: A Conversation on AI-powered Authentication and Zero Trust Architectures
Chengi Lin, CEO, Keypasco, in conversation with Rajarshi Dhar, Associate Director, Global Security Advisory, Frost & Sullivan, at the Cybersec India Expo 2026. Download This Transformation Growth Leadership Discussion with Chengi Lin From digital banking and...
Growth Opportunities in Enterprise Connectivity: See What AI and Embedded Security Can Do for Your Network Strategy
This blog is based on the analyses titled, 10 Strategic Imperatives and Top 10 Growth Opportunities in Enterprise Network Services, 2026, authored by Frost & Sullivan’s growth expert, Amrit Singh from the Enterprise Network Services team. Today, enterprise...
Stone-like Coatings: How Sustainability, Performance, and Architectural Innovation Are Reshaping Exterior Building Finishes
The convergence of sustainability goals, evolving design preferences, and cost-performance requirements is transforming the global exterior building finishes industry. Traditional materials such as natural stone and ceramic tiles are facing competition from innovative...
Food Safety Testing Under Pressure: What It Means for Companies Serving the Market
As testing volumes rise and laboratory workflows become more complex, organisations serving the food safety testing market must shift their focus from analytical performance alone to helping customers improve productivity, reduce risk, and optimise end-to-end...
BROWSE RECENT POSTS
Stone-like Coatings: How Sustainability, Performance, and Architectural Innovation Are Reshaping Exterior Building Finishes
The convergence of sustainability goals, evolving design preferences, and cost-performance requirements is transforming the global exterior building finishes industry. Traditional materials such as natural stone and ceramic tiles are facing competition from innovative...
Stone-like Coatings: How Sustainability, Performance, and Architectural Innovation Are Reshaping Exterior Building Finishes
The convergence of sustainability goals, evolving design preferences, and cost-performance requirements is transforming the global exterior building finishes industry. Traditional materials such as natural stone and ceramic tiles are facing competition from innovative...
Food Safety Testing Under Pressure: What It Means for Companies Serving the Market
As testing volumes rise and laboratory workflows become more complex, organisations serving the food safety testing market must shift their focus from analytical performance alone to helping customers improve productivity, reduce risk, and optimise end-to-end...
Food Safety Testing Under Pressure: What It Means for Companies Serving the Market
As testing volumes rise and laboratory workflows become more complex, organisations serving the food safety testing market must shift their focus from analytical performance alone to helping customers improve productivity, reduce risk, and optimise end-to-end...
Food Safety Testing Under Pressure: What It Means for Companies Serving the Market
As testing volumes rise and laboratory workflows become more complex, organisations serving the food safety testing market must shift their focus from analytical performance alone to helping customers improve productivity, reduce risk, and optimise end-to-end...
Food Safety Testing Under Pressure: What It Means for Companies Serving the Market
As testing volumes rise and laboratory workflows become more complex, organisations serving the food safety testing market must shift their focus from analytical performance alone to helping customers improve productivity, reduce risk, and optimise end-to-end...
Browse by Category
- All
- Big Data
- Cloud
- Customer Contact
- Consumer
- Digital Media
- Enterprise
- Mobile & Wireless
- The Internet of Things
Pushing the Boundaries of AI with Autonomous Agents, MLOps, and Ethical Frameworks
Opportunities for Maximizing the AI Impact in EnterprisesAI is rapidly becoming more powerful with customized services built on foundational models that cater to specific industries. From manufacturing and healthcare, to banking, finance, and retail, AI solutions are...
Next-gen Content Delivery Networks (CDNs) and Edge Services: 8 Ways for Providers to Improve Content Distribution, Security, and Digital Experiences
Content delivery networks (CDNs) and edge services are evolving to support the rising demand of digital content across industries. Traditionally, these were limited to boosting website performance and reducing latency by caching static content closer to end users. The...
Reimagining Connectivity in the Age of Digital Infrastructure: An Interview with Keri Gilder, CEO at Colt Technology Services
In this discussion, Lynda Stadtmueller from Frost & Sullivan interviews Keri Gilder from Colt Technology Services, shedding light on the telecommunication industry's shift toward software-defined networking, ESG (Environmental, Social, and Governance) initiatives,...
Growth Opportunity Newsletter – April 2025 Edition
Identify the Top Growth Opportunities Impacting the Healthcare, Life Sciences, Energy, Environment, Information & Communications Technology, Mobility, Industrials, Chemicals, Materials, Nutrition, Aerospace, Defense, Security, and Technology Landscapes Healthcare...
Emerging Growth Opportunities in Agentic AI
Business Models and Technology Strategies to Capitalize on Autonomous AI AgentsAgentic AI is more than just the next wave of automation — it represents a seismic shift in how businesses operate, compete, and create value. Unlike traditional AI that waits for...
Innovative Wireless Strategies for High-performance Connectivity: 5G, Private Networks, Wireless WAN, Fixed Wireless, and Network Slicing
Wireless technologies are rapidly evolving to support a hyper-digital world that is increasingly reliant on ubiquitous connectivity. Transformative megatrends, breakthroughs in emerging tech, and new business models are all drivers of this change. Consequently,...
Collaboration Between Legacy Automakers and Chinese OEMs Underscores a Pragmatic Path to Global Competitiveness
Partnerships between legacy automakers and Chinese OEMs are increasingly driven by a mix of technology gaps, cost pressures, and the need for expanded market access. The growing collaboration between legacy automakers and Chinese OEMs reflects a pragmatic shift in the...
Replacement Demand to Sustain Turkey’s Mature Bus Market
Electrification, digital connectivity, and automation to underpin stable, technology-led phase of development with otobus and midibus segments recovering after a difficult 2025. Growth conditions for Turkey’s bus market are becoming tighter as market maturity...
BostonGene Receives Frost & Sullivan’s 2026 Global Company of the Year for Advancing in AI-Driven Multimodal Oncology Platforms
BostonGene Receives Frost & Sullivan’s 2026 Global Company of the Year for Advancing in AI-Driven Multimodal Oncology Platforms
Growth Opportunities in Bio-identical Cosmetic Actives: Biotechnological Processes Transform Beauty Innovation
This blog is based on the analysis titled, Bio-identical Actives in Cosmetics via Biotechnological Processes, authored by Frost & Sullivan’s Chemicals & Advanced Materials growth expert, Abhishek Paul Choudhury, from the TechVision team. Bio-identical cosmetic...
Top Growth Opportunities in Next-generation Robotics and Autonomous Manufacturing
This blog is based on Frost & Sullivan’s “Top Growth Opportunities in Next-generation Robotics,” built from three Technology Opportunity Engine analyses. Developed by Frost & Sullivan’s growth expert, Varun Babu, from the TechVision Advanced Manufacturing and...
From Breakthroughs to Industrial-scale Impact: Scaling Cell and Gene Therapy for Commercial Success
This blog is based on the recent Frost & Sullivan analysis, “Growth Opportunities in Cell and Gene Therapeutics Market, forecast to 2030,” authored by Surbhi Gupta, Industry Principal, Healthcare & Life Sciences Practice. Cell and gene therapy (CGT)...
Collaboration Between Legacy Automakers and Chinese OEMs Underscores a Pragmatic Path to Global Competitiveness
Partnerships between legacy automakers and Chinese OEMs are increasingly driven by a mix of technology gaps, cost pressures, and the need for expanded market access. The growing collaboration between legacy automakers and Chinese OEMs reflects a pragmatic shift in the...
Replacement Demand to Sustain Turkey’s Mature Bus Market
Electrification, digital connectivity, and automation to underpin stable, technology-led phase of development with otobus and midibus segments recovering after a difficult 2025. Growth conditions for Turkey’s bus market are becoming tighter as market maturity...
BostonGene Receives Frost & Sullivan’s 2026 Global Company of the Year for Advancing in AI-Driven Multimodal Oncology Platforms
BostonGene Receives Frost & Sullivan’s 2026 Global Company of the Year for Advancing in AI-Driven Multimodal Oncology Platforms
Growth Opportunities in Bio-identical Cosmetic Actives: Biotechnological Processes Transform Beauty Innovation
This blog is based on the analysis titled, Bio-identical Actives in Cosmetics via Biotechnological Processes, authored by Frost & Sullivan’s Chemicals & Advanced Materials growth expert, Abhishek Paul Choudhury, from the TechVision team. Bio-identical cosmetic...
Top Growth Opportunities in Next-generation Robotics and Autonomous Manufacturing
This blog is based on Frost & Sullivan’s “Top Growth Opportunities in Next-generation Robotics,” built from three Technology Opportunity Engine analyses. Developed by Frost & Sullivan’s growth expert, Varun Babu, from the TechVision Advanced Manufacturing and...
From Breakthroughs to Industrial-scale Impact: Scaling Cell and Gene Therapy for Commercial Success
This blog is based on the recent Frost & Sullivan analysis, “Growth Opportunities in Cell and Gene Therapeutics Market, forecast to 2030,” authored by Surbhi Gupta, Industry Principal, Healthcare & Life Sciences Practice. Cell and gene therapy (CGT)...
Collaboration Between Legacy Automakers and Chinese OEMs Underscores a Pragmatic Path to Global Competitiveness
Partnerships between legacy automakers and Chinese OEMs are increasingly driven by a mix of technology gaps, cost pressures, and the need for expanded market access. The growing collaboration between legacy automakers and Chinese OEMs reflects a pragmatic shift in the...
Replacement Demand to Sustain Turkey’s Mature Bus Market
Electrification, digital connectivity, and automation to underpin stable, technology-led phase of development with otobus and midibus segments recovering after a difficult 2025. Growth conditions for Turkey’s bus market are becoming tighter as market maturity...
BostonGene Receives Frost & Sullivan’s 2026 Global Company of the Year for Advancing in AI-Driven Multimodal Oncology Platforms
BostonGene Receives Frost & Sullivan’s 2026 Global Company of the Year for Advancing in AI-Driven Multimodal Oncology Platforms
Growth Opportunities in Bio-identical Cosmetic Actives: Biotechnological Processes Transform Beauty Innovation
This blog is based on the analysis titled, Bio-identical Actives in Cosmetics via Biotechnological Processes, authored by Frost & Sullivan’s Chemicals & Advanced Materials growth expert, Abhishek Paul Choudhury, from the TechVision team. Bio-identical cosmetic...
Top Growth Opportunities in Next-generation Robotics and Autonomous Manufacturing
This blog is based on Frost & Sullivan’s “Top Growth Opportunities in Next-generation Robotics,” built from three Technology Opportunity Engine analyses. Developed by Frost & Sullivan’s growth expert, Varun Babu, from the TechVision Advanced Manufacturing and...
From Breakthroughs to Industrial-scale Impact: Scaling Cell and Gene Therapy for Commercial Success
This blog is based on the recent Frost & Sullivan analysis, “Growth Opportunities in Cell and Gene Therapeutics Market, forecast to 2030,” authored by Surbhi Gupta, Industry Principal, Healthcare & Life Sciences Practice. Cell and gene therapy (CGT)...
Collaboration Between Legacy Automakers and Chinese OEMs Underscores a Pragmatic Path to Global Competitiveness
Partnerships between legacy automakers and Chinese OEMs are increasingly driven by a mix of technology gaps, cost pressures, and the need for expanded market access. The growing collaboration between legacy automakers and Chinese OEMs reflects a pragmatic shift in the...
Replacement Demand to Sustain Turkey’s Mature Bus Market
Electrification, digital connectivity, and automation to underpin stable, technology-led phase of development with otobus and midibus segments recovering after a difficult 2025. Growth conditions for Turkey’s bus market are becoming tighter as market maturity...
BostonGene Receives Frost & Sullivan’s 2026 Global Company of the Year for Advancing in AI-Driven Multimodal Oncology Platforms
BostonGene Receives Frost & Sullivan’s 2026 Global Company of the Year for Advancing in AI-Driven Multimodal Oncology Platforms
Growth Opportunities in Bio-identical Cosmetic Actives: Biotechnological Processes Transform Beauty Innovation
This blog is based on the analysis titled, Bio-identical Actives in Cosmetics via Biotechnological Processes, authored by Frost & Sullivan’s Chemicals & Advanced Materials growth expert, Abhishek Paul Choudhury, from the TechVision team. Bio-identical cosmetic...
Top Growth Opportunities in Next-generation Robotics and Autonomous Manufacturing
This blog is based on Frost & Sullivan’s “Top Growth Opportunities in Next-generation Robotics,” built from three Technology Opportunity Engine analyses. Developed by Frost & Sullivan’s growth expert, Varun Babu, from the TechVision Advanced Manufacturing and...
From Breakthroughs to Industrial-scale Impact: Scaling Cell and Gene Therapy for Commercial Success
This blog is based on the recent Frost & Sullivan analysis, “Growth Opportunities in Cell and Gene Therapeutics Market, forecast to 2030,” authored by Surbhi Gupta, Industry Principal, Healthcare & Life Sciences Practice. Cell and gene therapy (CGT)...
Collaboration Between Legacy Automakers and Chinese OEMs Underscores a Pragmatic Path to Global Competitiveness
Partnerships between legacy automakers and Chinese OEMs are increasingly driven by a mix of technology gaps, cost pressures, and the need for expanded market access. The growing collaboration between legacy automakers and Chinese OEMs reflects a pragmatic shift in the...
Replacement Demand to Sustain Turkey’s Mature Bus Market
Electrification, digital connectivity, and automation to underpin stable, technology-led phase of development with otobus and midibus segments recovering after a difficult 2025. Growth conditions for Turkey’s bus market are becoming tighter as market maturity...
BostonGene Receives Frost & Sullivan’s 2026 Global Company of the Year for Advancing in AI-Driven Multimodal Oncology Platforms
BostonGene Receives Frost & Sullivan’s 2026 Global Company of the Year for Advancing in AI-Driven Multimodal Oncology Platforms
Growth Opportunities in Bio-identical Cosmetic Actives: Biotechnological Processes Transform Beauty Innovation
This blog is based on the analysis titled, Bio-identical Actives in Cosmetics via Biotechnological Processes, authored by Frost & Sullivan’s Chemicals & Advanced Materials growth expert, Abhishek Paul Choudhury, from the TechVision team. Bio-identical cosmetic...
Top Growth Opportunities in Next-generation Robotics and Autonomous Manufacturing
This blog is based on Frost & Sullivan’s “Top Growth Opportunities in Next-generation Robotics,” built from three Technology Opportunity Engine analyses. Developed by Frost & Sullivan’s growth expert, Varun Babu, from the TechVision Advanced Manufacturing and...
From Breakthroughs to Industrial-scale Impact: Scaling Cell and Gene Therapy for Commercial Success
This blog is based on the recent Frost & Sullivan analysis, “Growth Opportunities in Cell and Gene Therapeutics Market, forecast to 2030,” authored by Surbhi Gupta, Industry Principal, Healthcare & Life Sciences Practice. Cell and gene therapy (CGT)...
Collaboration Between Legacy Automakers and Chinese OEMs Underscores a Pragmatic Path to Global Competitiveness
Partnerships between legacy automakers and Chinese OEMs are increasingly driven by a mix of technology gaps, cost pressures, and the need for expanded market access. The growing collaboration between legacy automakers and Chinese OEMs reflects a pragmatic shift in the...
Replacement Demand to Sustain Turkey’s Mature Bus Market
Electrification, digital connectivity, and automation to underpin stable, technology-led phase of development with otobus and midibus segments recovering after a difficult 2025. Growth conditions for Turkey’s bus market are becoming tighter as market maturity...
BostonGene Receives Frost & Sullivan’s 2026 Global Company of the Year for Advancing in AI-Driven Multimodal Oncology Platforms
BostonGene Receives Frost & Sullivan’s 2026 Global Company of the Year for Advancing in AI-Driven Multimodal Oncology Platforms
Growth Opportunities in Bio-identical Cosmetic Actives: Biotechnological Processes Transform Beauty Innovation
This blog is based on the analysis titled, Bio-identical Actives in Cosmetics via Biotechnological Processes, authored by Frost & Sullivan’s Chemicals & Advanced Materials growth expert, Abhishek Paul Choudhury, from the TechVision team. Bio-identical cosmetic...
Top Growth Opportunities in Next-generation Robotics and Autonomous Manufacturing
This blog is based on Frost & Sullivan’s “Top Growth Opportunities in Next-generation Robotics,” built from three Technology Opportunity Engine analyses. Developed by Frost & Sullivan’s growth expert, Varun Babu, from the TechVision Advanced Manufacturing and...
From Breakthroughs to Industrial-scale Impact: Scaling Cell and Gene Therapy for Commercial Success
This blog is based on the recent Frost & Sullivan analysis, “Growth Opportunities in Cell and Gene Therapeutics Market, forecast to 2030,” authored by Surbhi Gupta, Industry Principal, Healthcare & Life Sciences Practice. Cell and gene therapy (CGT)...
Collaboration Between Legacy Automakers and Chinese OEMs Underscores a Pragmatic Path to Global Competitiveness
Partnerships between legacy automakers and Chinese OEMs are increasingly driven by a mix of technology gaps, cost pressures, and the need for expanded market access. The growing collaboration between legacy automakers and Chinese OEMs reflects a pragmatic shift in the...
Replacement Demand to Sustain Turkey’s Mature Bus Market
Electrification, digital connectivity, and automation to underpin stable, technology-led phase of development with otobus and midibus segments recovering after a difficult 2025. Growth conditions for Turkey’s bus market are becoming tighter as market maturity...
BostonGene Receives Frost & Sullivan’s 2026 Global Company of the Year for Advancing in AI-Driven Multimodal Oncology Platforms
BostonGene Receives Frost & Sullivan’s 2026 Global Company of the Year for Advancing in AI-Driven Multimodal Oncology Platforms
Growth Opportunities in Bio-identical Cosmetic Actives: Biotechnological Processes Transform Beauty Innovation
This blog is based on the analysis titled, Bio-identical Actives in Cosmetics via Biotechnological Processes, authored by Frost & Sullivan’s Chemicals & Advanced Materials growth expert, Abhishek Paul Choudhury, from the TechVision team. Bio-identical cosmetic...
Top Growth Opportunities in Next-generation Robotics and Autonomous Manufacturing
This blog is based on Frost & Sullivan’s “Top Growth Opportunities in Next-generation Robotics,” built from three Technology Opportunity Engine analyses. Developed by Frost & Sullivan’s growth expert, Varun Babu, from the TechVision Advanced Manufacturing and...
From Breakthroughs to Industrial-scale Impact: Scaling Cell and Gene Therapy for Commercial Success
This blog is based on the recent Frost & Sullivan analysis, “Growth Opportunities in Cell and Gene Therapeutics Market, forecast to 2030,” authored by Surbhi Gupta, Industry Principal, Healthcare & Life Sciences Practice. Cell and gene therapy (CGT)...
Collaboration Between Legacy Automakers and Chinese OEMs Underscores a Pragmatic Path to Global Competitiveness
Partnerships between legacy automakers and Chinese OEMs are increasingly driven by a mix of technology gaps, cost pressures, and the need for expanded market access. The growing collaboration between legacy automakers and Chinese OEMs reflects a pragmatic shift in the...
Replacement Demand to Sustain Turkey’s Mature Bus Market
Electrification, digital connectivity, and automation to underpin stable, technology-led phase of development with otobus and midibus segments recovering after a difficult 2025. Growth conditions for Turkey’s bus market are becoming tighter as market maturity...
BostonGene Receives Frost & Sullivan’s 2026 Global Company of the Year for Advancing in AI-Driven Multimodal Oncology Platforms
BostonGene Receives Frost & Sullivan’s 2026 Global Company of the Year for Advancing in AI-Driven Multimodal Oncology Platforms
Growth Opportunities in Bio-identical Cosmetic Actives: Biotechnological Processes Transform Beauty Innovation
This blog is based on the analysis titled, Bio-identical Actives in Cosmetics via Biotechnological Processes, authored by Frost & Sullivan’s Chemicals & Advanced Materials growth expert, Abhishek Paul Choudhury, from the TechVision team. Bio-identical cosmetic...
Top Growth Opportunities in Next-generation Robotics and Autonomous Manufacturing
This blog is based on Frost & Sullivan’s “Top Growth Opportunities in Next-generation Robotics,” built from three Technology Opportunity Engine analyses. Developed by Frost & Sullivan’s growth expert, Varun Babu, from the TechVision Advanced Manufacturing and...
From Breakthroughs to Industrial-scale Impact: Scaling Cell and Gene Therapy for Commercial Success
This blog is based on the recent Frost & Sullivan analysis, “Growth Opportunities in Cell and Gene Therapeutics Market, forecast to 2030,” authored by Surbhi Gupta, Industry Principal, Healthcare & Life Sciences Practice. Cell and gene therapy (CGT)...
